首页> 美国卫生研究院文献>Protein Science : A Publication of the Protein Society >Conformationally constrained analogs of protein kinase inhibitor (6-22)amide: effect of turn structures in the center of the peptide on inhibition of cAMP-dependent protein kinase.
【2h】

Conformationally constrained analogs of protein kinase inhibitor (6-22)amide: effect of turn structures in the center of the peptide on inhibition of cAMP-dependent protein kinase.

机译:构象受限的蛋白激酶抑制剂(6-22)酰胺类似物:肽中心的转弯结构对cAMP依赖性蛋白激酶抑制的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The high-affinity interaction between protein kinase inhibitor (PKI)(6-22)amide(Thr6-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly- Arg-Arg-Asn- Ala-Ile22-NH2) and the catalytic subunit of cAMP-dependent protein kinase requires both the N-terminal Thr6 to Ile11 sequence of the inhibitor peptide and its C-terminal pseudosubstrate site comprised of Arg15 to Ile22. Small angle X-ray scattering data indicate that PKI(6-22)amide has a compact, rather than extended, structure in solution (Reed J et al., 1989, Biochem J 264:371-380). CD spectroscopic analysis of the PKI peptide led to the suggestion that a beta-turn structure might be located in the -Ala12-Ser-Gly-Arg15-connecting sequence in the middle of the molecule (Reed J, Kinzel V, Cheng HC, Walsh DA, 1987, Biochemistry 26:7641-7647). To investigate this possibility further, conformationally constrained and flexible analogs of PKI(6-22)amide were synthesized and used to study the structure-function relationships of this central portion of the inhibitor. (Des12-14)PKI(6-22) amide exhibited over a 200-fold loss in inhibitory activity. Replacement of the omitted -Ala12-Ser-Gly14-sequence with aminocaprylic acid yielded an analog that regained more than 90% of the lost binding energy. The D-alanine14 PKI analog was as potent as the parent peptide, whereas the beta-alanine14 and the sarcosine14 analogs were only 10-fold less active. Several peptides that promoted a beta-turn structure at residues 12-15 showed about 200-fold decreases in inhibitory activity. Two constrained analogs that could not assume a beta-turn conformation were only 30-fold less potent than PKI(6-22)amide. Thus, the structure of the central connecting portion of the PKI peptide, encompassing residues 12-15, greatly influences its ability to effectively bind to and inhibit the catalytic subunit. We conclude, however, that a formal beta-turn at this position is not required and is actually detrimental for a high-affinity interaction of PKI(6-22)amide with the enzyme. These results are interpreted in light of the Fourier-transform infrared spectra of the peptide analogs and the crystal structure of the peptide bound at the active site of the protein kinase (Knighton DR et al., 1991b, Science 253:414-420).
机译:蛋白激酶抑制剂(PKI)(6-22)酰胺(Thr6-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala之间的高亲和力相互作用-Ile22-NH2)和cAMP依赖性蛋白激酶的催化亚基需要抑制剂肽的N端Thr6至Ile11序列及其C端由Arg15至Ile22组成的假底物位点。小角度X射线散射数据表明,PKI(6-22)酰胺在溶液中具有致密而不是延伸的结构(Reed J等人,1989,Biochem J 264:371-380)。对PKI肽的CD光谱分析表明,β-转角结构可能位于分子中间的-Ala12-Ser-Gly-Arg15连接序列中(Reed J,Kinzel V,Cheng HC,Walsh DA,1987,Biochemistry 26:7641-7647)。为了进一步研究这种可能性,合成了PKI(6-22)酰胺的构象约束和柔性类似物,并用于研究抑制剂这一中心部分的结构-功能关系。 (Des12-14)PKI(6-22)酰胺的抑制活性降低了200倍以上。用氨基辛酸代替省略的-Ala12-Ser-Gly14-序列,得到的类似物重新获得了超过90%的结合能损失。 D-丙氨酸14 PKI类似物与亲本肽一样有效,而β-丙氨酸14和肌氨酸14类似物的活性仅低10倍。在残基12-15处促进β转角结构的几种肽显示抑制活性降低了约200倍。不能假定β转角构象的两个受约束类似物的效力仅比PKI(6-22)酰胺低30倍。因此,包含残基12-15的PKI肽的中央连接部分的结构极大地影响了其有效结合并抑制催化亚基的能力。但是,我们得出的结论是,不需要在此位置进行正式的β转角,实际上对PKI(6-22)酰胺与酶的高亲和力相互作用是有害的。这些结果是根据肽类似物的傅立叶变换红外光谱和结合在蛋白激酶活性位点上的肽的晶体结构来解释的(Knighton DR等,1991b,Science 253:414-420)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号